BACKGROUND: Hypophosphataemia after a hepatectomy suggests hepatic regeneration. It was hypothesized that the absence of hypophosphataemia is associated with post-operative hepatic insufficiency (PHI) and complications. METHODS: Patients who underwent a major hepatectomy from 2000-2012 at a single institution were identified. Post-operative serum phosphorus levels were assessed. Primary outcomes were PHI (peak bilirubin >7 mg/dl), major complications, and 30- and 90-day mortality. RESULTS: Seven hundred and nineteen out of 749 patients had post-operative phosphorus levels available. PHI and major complications occurred in 63 (8.8%) and 169 (23.5%) patients, respectively. Thirty- and 90-day mortality were 4.0% and 5.4%, respectively. The median phosphorus level on post-operative-day (POD) 2 was 2.2 mg/dl; 231 patients (32.1%) had phosphorus >2.4 on POD2. Patients with POD2 phosphorus >2.4 had a significantly higher incidence of PHI, major complications and mortality. On multivariate analysis, POD2 phosphorus >2.4 remained a significant risk factor for PHI [(hazard ratio HR):1.78; 95% confidence interval (CI):1.02-3.17; P = 0.048], major complications (HR:1.57; 95%CI:1.02-2.47; P = 0.049), 30-day mortality (HR:2.70; 95%CI:1.08-6.76; P = 0.034) and 90-day mortality (HR:2.51; 95%CI:1.03-6.15; P = 0.044). Similarly, patients whose phosphorus level reached nadir after POD3 had higher PHI, major complications and mortality. CONCLUSION: Elevated POD2 phosphorus levels >2.4 mg/dl and a delayed nadir in phosphorus beyond POD3 are associated with increased post-operative hepatic insufficiency, major complications and early mortality. Failure to develop hypophosphataemia within 72 h after a major hepatectomy may reflect insufficient liver remnant regeneration.
BACKGROUND: Hypophosphataemia after a hepatectomy suggests hepatic regeneration. It was hypothesized that the absence of hypophosphataemia is associated with post-operative hepatic insufficiency (PHI) and complications. METHODS:Patients who underwent a major hepatectomy from 2000-2012 at a single institution were identified. Post-operative serum phosphorus levels were assessed. Primary outcomes were PHI (peak bilirubin >7 mg/dl), major complications, and 30- and 90-day mortality. RESULTS: Seven hundred and nineteen out of 749 patients had post-operative phosphorus levels available. PHI and major complications occurred in 63 (8.8%) and 169 (23.5%) patients, respectively. Thirty- and 90-day mortality were 4.0% and 5.4%, respectively. The median phosphorus level on post-operative-day (POD) 2 was 2.2 mg/dl; 231 patients (32.1%) had phosphorus >2.4 on POD2. Patients with POD2 phosphorus >2.4 had a significantly higher incidence of PHI, major complications and mortality. On multivariate analysis, POD2 phosphorus >2.4 remained a significant risk factor for PHI [(hazard ratio HR):1.78; 95% confidence interval (CI):1.02-3.17; P = 0.048], major complications (HR:1.57; 95%CI:1.02-2.47; P = 0.049), 30-day mortality (HR:2.70; 95%CI:1.08-6.76; P = 0.034) and 90-day mortality (HR:2.51; 95%CI:1.03-6.15; P = 0.044). Similarly, patients whose phosphorus level reached nadir after POD3 had higher PHI, major complications and mortality. CONCLUSION: Elevated POD2 phosphorus levels >2.4 mg/dl and a delayed nadir in phosphorus beyond POD3 are associated with increased post-operative hepatic insufficiency, major complications and early mortality. Failure to develop hypophosphataemia within 72 h after a major hepatectomy may reflect insufficient liver remnant regeneration.
Authors: Darren V Mann; Wynnie W M Lam; N Magnus Hjelm; Nina M C So; David K W Yeung; Constantine Metreweli; Wan Y Lau Journal: Ann Surg Date: 2002-03 Impact factor: 12.969
Authors: J J Pomposelli; E A Pomfret; D L Burns; A Lally; A Sorcini; F D Gordon; W D Lewis; R Jenkins Journal: Liver Transpl Date: 2001-07 Impact factor: 5.799
Authors: D A Kooby; K L Zakian; S N Challa; C Matei; H Petrowsky; H H Yoo; J A Koutcher; Y Fong Journal: Cancer Res Date: 2000-07-15 Impact factor: 12.701
Authors: Henkie P Tan; Ralph Madeb; Stephen J Kovach; Mark Orloff; Luis Mieles; Lesley A Johnson; Adel Bozorgzadeh; Amadeo Marcos Journal: Transplantation Date: 2003-10-15 Impact factor: 4.939
Authors: John T Mullen; Dario Ribero; Srinevas K Reddy; Matteo Donadon; Daria Zorzi; Shiva Gautam; Eddie K Abdalla; Steven A Curley; Lorenzo Capussotti; Bryan M Clary; Jean-Nicolas Vauthey Journal: J Am Coll Surg Date: 2007-02-15 Impact factor: 6.113
Authors: Julie Hallet; Paul J Karanicolas; Francis S W Zih; Eva Cheng; Julia Wong; Sherif Hanna; Natalie G Coburn; Calvin H L Law Journal: Hepatobiliary Surg Nutr Date: 2016-06 Impact factor: 7.293
Authors: Jian Zheng; Ilya G Glezerman; Eran Sadot; Anjuli McNeil; Cristina Zarama; Mithat Gönen; John Creasy; Linda M Pak; Vinod P Balachandran; Michael I D'Angelica; Peter J Allen; Ronald P DeMatteo; T Peter Kingham; William R Jarnagin; Edgar A Jaimes Journal: J Am Coll Surg Date: 2017-07-06 Impact factor: 6.113
Authors: Garth S Herbert; Kara B Prussing; Amber L Simpson; Michael I D'Angelica; Peter J Allen; Ronald P DeMatteo; William R Jarnagin; T Peter Kingham Journal: HPB (Oxford) Date: 2015-09-19 Impact factor: 3.647
Authors: Linda M Pak; Jayasree Chakraborty; Mithat Gonen; William C Chapman; Richard K G Do; Bas Groot Koerkamp; Kees Verhoef; Ser Yee Lee; Marco Massani; Eric P van der Stok; Amber L Simpson Journal: J Am Coll Surg Date: 2018-02-15 Impact factor: 6.113